<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">25461</article-id><article-id pub-id-type="doi">10.7554/eLife.25461</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title><italic>APOL1</italic> renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-42884"><name><surname>Cooper</surname><given-names>Anneli</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1159-142X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80770"><name><surname>Ilboudo</surname><given-names>Hamidou</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80779"><name><surname>Alibu</surname><given-names>V Pius</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80730"><name><surname>Ravel</surname><given-names>Sophie</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80734"><name><surname>Enyaru</surname><given-names>John</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42874"><name><surname>Weir</surname><given-names>William</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80731"><name><surname>Noyes</surname><given-names>Harry</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28860"><name><surname>Capewell</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42883"><name><surname>Camara</surname><given-names>Mamadou</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80733"><name><surname>Milet</surname><given-names>Jacqueline</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42886"><name><surname>Jamonneau</surname><given-names>Vincent</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80769"><name><surname>Camara</surname><given-names>Oumou</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80732"><name><surname>matovu</surname><given-names>Enock</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42887"><name><surname>Bucheton</surname><given-names>Bruno</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-41913"><name><surname>MacLeod</surname><given-names>Annette</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0150-5049</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Wellcome Trust Centre for Molecular Parasitology</institution>, <institution>University of Glasgow</institution>, <addr-line><named-content content-type="city">Glasgow</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution>Centre International de Recherche-Développement sur l'Elevage en zone Subhumide</institution>, <addr-line><named-content content-type="city">Bobo-Dioulasso</named-content></addr-line>, <country>Burkina Faso</country></aff><aff id="aff3"><institution content-type="dept">College of Natural Sciences</institution>, <institution>Makerere University</institution>, <addr-line><named-content content-type="city">Kampala</named-content></addr-line>, <country>Uganda</country></aff><aff id="aff4"><institution content-type="dept">Unité Mixte de Recherche IRD-CIRAD 177</institution>, <institution>Institut de Recherche pour le Développement</institution>, <addr-line><named-content content-type="city">Montpellier</named-content></addr-line>, <country>France</country></aff><aff id="aff5"><institution>Programme National de Lutte contre la Trypanosomiase Humaine Africaine</institution>, <addr-line><named-content content-type="city">Conakry</named-content></addr-line>, <country>Guinea</country></aff><aff id="aff6"><institution content-type="dept">College of Veterinary Medicine, Animal Resources and Biosecurity</institution>, <institution>Makerere University</institution>, <addr-line><named-content content-type="city">Kampala</named-content></addr-line>, <country>Uganda</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-81434"><name><surname>Tishkoff</surname><given-names>Sarah</given-names></name><role>Reviewing editor</role><aff><institution>University of Pennsylvania</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>annette.macleod@glasgow.ac.uk</email> (AM);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>24</day><month>05</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e25461</elocation-id><history><date date-type="received"><day>25</day><month>01</month><year>2017</year></date><date date-type="accepted"><day>22</day><month>05</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Cooper et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Cooper et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-25461-v2.pdf"/><abstract><p>Reduced susceptibility to infectious disease can increase the frequency of otherwise deleterious alleles. In populations of African ancestry, two <italic>apolipoprotein-L1 (APOL1</italic>) variants with a recessive kidney disease risk, named G1 and G2, occur at high frequency. APOL1 is a trypanolytic protein that confers innate resistance to most African trypanosomes, but not <italic>Trypanosoma brucei rhodesiense</italic> or <italic>T.b. gambiense,</italic> which cause human African trypanosomiasis. In this case-control study we test the prevailing hypothesis that these <italic>APOL1</italic> variants reduce trypanosomiasis susceptibility, resulting in their positive selection in sub-Saharan Africa. We demonstrate a five-fold dominant protective association for G2 against <italic>T.b. rhodesiense</italic> infection. Furthermore, we report unpredicted strong opposing associations with <italic>T.b. gambiense</italic> disease outcome. G2 associates with faster progression of <italic>T.b. gambiense</italic> trypanosomiasis, while G1 associates with asymptomatic carriage and undetectable parasitemia. These results implicate both forms of human African trypanosomiasis in the selection and persistence of otherwise detrimental <italic>APOL1</italic> kidney disease variants.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>095201/Z/10/Z</award-id><principal-award-recipient><name><surname>Cooper</surname><given-names>Anneli</given-names></name><name><surname>Weir</surname><given-names>William</given-names></name><name><surname>Capewell</surname><given-names>Paul</given-names></name><name><surname>MacLeod</surname><given-names>Annette</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003388</institution-id><institution>Ministère des Affaires Étrangères</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ilboudo</surname><given-names>Hamidou</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004423</institution-id><institution>World Health Organization</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Camara</surname><given-names>Mamadou</given-names></name><name><surname>Camara</surname><given-names>Oumou</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003388</institution-id><institution>Ministère des Affaires Étrangères</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ravel</surname><given-names>Sophie</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>99310</award-id><principal-award-recipient><name><surname>Ilboudo</surname><given-names>Hamidou</given-names></name><name><surname>Alibu</surname><given-names>V Pius</given-names></name><name><surname>Enyaru</surname><given-names>John</given-names></name><name><surname>Noyes</surname><given-names>Harry</given-names></name><name><surname>Camara</surname><given-names>Mamadou</given-names></name><name><surname>Jamonneau</surname><given-names>Vincent</given-names></name><name><surname>matovu</surname><given-names>Enock</given-names></name><name><surname>Bucheton</surname><given-names>Bruno</given-names></name><name><surname>MacLeod</surname><given-names>Annette</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Participants were identified through healthcare providers, community engagement and active field surveillance in association with the national control programmes. Written informed consent for sample collection, analysis and publication of anonymised data was obtained from all participants by trained local healthcare workers. Subjects or their legal guardian gave consent as a signature or a thumbprint after receiving standardised information in English, French or their local language, as preferred, and were free to withdraw from the study at any time. Efforts were made to ensure the engagement of all local stake holders and approval was obtained from local leaders in each study area where appropriate. Ethical approvals for the study were obtained from within the TrypanoGEN Project following H3Africa Consortium guidelines for informed consent, from Comité Consultatif de Déontologie et d'Ethique (CCDE) at the Institut de recherche pour le développement (IRD; 10/06/2013) for the Guinea study, and from the Uganda National Council for Science and Technology (UNCST; 21/03/2013) for the Uganda study. Research procedures were also approved by the University of Glasgow MVLS Ethics Committee for Non-Clinical Research Involving Human Subjects (Reference no. 200120043).</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-25461-supp-v2.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>